BioCentury
ARTICLE | Financial News

bioMerieux spinout bioTheranostics raises $32M

January 22, 2016 2:09 AM UTC

bioTheranostics Inc. raised $32 million in an equity round and said it will spin out from parent company bioMerieux S.A. (Euronext:BIM). MVM Life Science Partners led the round, in which Canepa Advanced Healthcare Fund and HealthQuest Capital also participated.

bioMerieux previously said it was seeking outside partners to accelerate the growth of bioTheranostics, which markets molecular-based cancer tests Breast Cancer Index (BCI) and CancerTYPE ID. ...